XML 47 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net income (loss) $ 3,482,000 $ (7,601,000) $ (16,557,000)
Adjustments to reconcile net income (loss) to cash and cash equivalents provided by (used in) operating activities:      
Depreciation and amortization 6,336,000 6,094,000 6,578,000
Bad debt expense 1,147,000 991,000 727,000
Stock-based compensation expense 8,976,000 10,598,000 11,947,000
Deferred income taxes 531,000 493,000 130,000
Other items, net 118,000 (851,000) (869,000)
Changes in assets and liabilities, net of effects from acquisition:      
Accounts receivable 361,000 2,634,000 (8,261,000)
Prepaid expenses and other assets 892,000 10,303,000 (5,514,000)
Deferred contract costs 3,146,000    
Deferred contract costs   (6,730,000) 0
Accounts payable and accrued expenses (2,306,000) (10,936,000) 5,242,000
Deferred revenue (3,383,000) (3,765,000) 3,581,000
Cash and cash equivalents provided by (used in) operating activities 13,008,000 1,230,000 (2,996,000)
Cash flows from investing activities      
Purchases of property and equipment (986,000) (2,045,000) (2,790,000)
Payment of internal-use software development costs (2,721,000) (894,000) (293,000)
Acquisition, net of cash acquired 0 0 (2,177,000)
Cash and cash equivalents used in investing activities (3,707,000) (2,939,000) (5,260,000)
Cash flows from financing activities      
Repayment of finance leases (2,209,000) (2,241,000) (2,840,000)
Proceeds from exercise of stock options 974,000 1,106,000 1,428,000
Payment of statutory tax withholding related to net-share settlement of restricted stock units (3,389,000) (2,959,000) (2,727,000)
Cash and cash equivalents used in financing activities (4,624,000) (4,094,000) (4,139,000)
Effect of currency exchange rate changes on cash and cash equivalents (77,000) (434,000) 397,000
Net increase (decrease) in cash and cash equivalents 4,600,000 (6,237,000) (11,998,000)
Cash and cash equivalents, beginning of period 47,185,000 53,422,000  
Cash and cash equivalents, end of period 51,785,000 47,185,000 53,422,000
Supplemental disclosure of cash flow information      
Cash paid for interest 215,000 30,000 111,000
Cash paid for income taxes, net 62,000 113,000 196,000
Supplemental disclosure of noncash investing and financing activities      
Accrued capital expenditures 15,000 68,000 80,000
Finance lease obligations entered into for the purchase of fixed assets $ 46,000 $ 4,217,000 $ 567,000